{"id":"W4401327466","doi":"10.1200/jco.2024.42.16_suppl.7540","title":"Long-term follow-up from the phase 1/2 MajesTEC-1 trial of teclistamab in patients with relapsed/refractory multiple myeloma.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Janssen Biotech","keywords":"Medicine; Refractory (planetary science); Multiple myeloma; Internal medicine; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004349052,0.0007504978,0.001650433,0.0003022322,0.0007705219,0.001544185,0.0005772727,0.001027415,0.003087983],"category_scores_gemma":[0.002410983,0.0004111247,0.001589602,0.0005073891,0.0003912635,0.001078465,0.0007702308,0.002796065,0.0007820349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001053118,"about_ca_system_score_gemma":0.001052989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001154066,"about_ca_topic_score_gemma":0.00312128,"domain_scores_codex":[0.9989058,0.0003799289,0.00009953006,0.0002018484,0.0001724513,0.0002404642],"domain_scores_gemma":[0.9980248,0.0002981891,0.0006506343,0.0001988991,0.0001837088,0.0006437353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5766188,0.01010243,0.1512915,0.002125421,0.01231662,0.001268942,0.0006087366,0.00478139,0.01670005,0.000480072,0.03556009,0.188146],"study_design_scores_gemma":[0.1886827,0.1806407,0.5688333,0.0006124705,0.01238209,0.002036199,0.0002521475,0.002462639,0.003778896,0.0008259726,0.03934728,0.0001455123],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9657099,0.01542507,0.0008739724,0.001393511,0.0002653913,0.001036063,0.009894394,0.00009999476,0.00530176],"genre_scores_gemma":[0.9651837,0.002700654,0.0007103008,0.002874377,0.0003212866,0.0009936445,0.02446681,0.00003670505,0.002712609],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004349052,"threshold_uncertainty_score":0.02300024,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09953379128334754,"score_gpt":0.455771068122289,"score_spread":0.3562372768389414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}